Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.

about

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q39124690

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Utility of prospective patholo ...... osis and renal cell carcinoma.

@en

Utility of prospective patholo ...... osis and renal cell carcinoma.

@nl

type

Item

label

Utility of prospective patholo ...... osis and renal cell carcinoma.

@en

Utility of prospective patholo ...... osis and renal cell carcinoma.

@nl

prefLabel

Utility of prospective patholo ...... osis and renal cell carcinoma.

@en

Utility of prospective patholo ...... osis and renal cell carcinoma.

@nl

P1476

Utility of prospective patholo ...... osis and renal cell carcinoma.

@en

P2093

Emily Glogowski

http://www.w3.org/2001/XMLSchema#string

Jonathan A Coleman

http://www.w3.org/2001/XMLSchema#string

Kelly L Stratton

http://www.w3.org/2001/XMLSchema#string

Paul Russo

http://www.w3.org/2001/XMLSchema#string

Rohini Rau-Murthy

http://www.w3.org/2001/XMLSchema#string

Ryan P Kopp

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a rapid autopsy report of metastatic renal cell carcinoma.

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report.

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.

Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

P304

2452-2458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30605

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth Offit

Kasmintan A Schrader

P577

2017-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28171700

http://www.w3.org/2001/XMLSchema#string